...
首页> 外文期刊>Radiation oncology >Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
【24h】

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy

机译:碘125前列腺近距离放射治疗中实时术中定制链接种子的处方剂量与剂量优势之间的关系分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to investigate the differences in the dosimetric advantage of using intraoperatively built custom-linked (IBCL) seeds between permanent iodine-125 (I-125) seed implantation (PI) alone and PI followed by external-beam radiation therapy (EBRT) for prostate cancer. We reviewed the records of 62 patients with localized prostate cancer who received transperineal interstitial brachytherapy with I-125 using free seeds or IBCL seeds. Twenty-four low- and intermediate-risk patients underwent PI alone with the prescribed dose of 160?Gy, and 39 high-risk patients underwent PI with 110?Gy, followed by EBRT with 45?Gy (PI + EBRT). Intraoperative and post-implant dosimetric parameters 1?month after implantation were collected and analyzed. The numbers of patients implanted with free seeds and IBCL seeds were 14 (58.3%) and 10 (41.7%), respectively, in the PI group and 25 (65.8%) and 13 (34.2%), respectively, in the PI + EBRT group. In the PI group, although there were significant differences in prostate V100 (p?=?0.003) and D90 (p?=?0.009) and rectum V100 (p?=?0.026) on intraoperative dosimetry, these differences were not found on post-implant dosimetry. In the PI + EBRT group, the dosimetric parameters of IBCL seeds, such as prostate V200 (p?=?0.013) and V250 (p?=?0.010) and urethra D30 (p?=?0.038), were better than those of free seeds on intraoperative dosimetry. Furthermore, even on post-implant dosimetry, prostate D90 (p?=?0.004), V150 (p?=?0.001), and homogeneity index (HI, p?=?0.001), as well as V200 (p?=?0.001) and V250 (p?=?0.020), and urethra D5 (p?=?0.008) as well as D30 (p?=?0.003) had a better dosimetric quality in IBCL seeds than in free seeds. There was no significant difference in the operation time between free seeds and IBCL seeds in each PI and PI + EBRT group. Our results reveal that greater dosimetric benefits could be obtained using IBCL seeds in the case of permanent implantation with a lower prescribed dose, such as PI + EBRT, rather than PI alone.
机译:这项研究的目的是调查使用术中定制的链接(IBCL)种子在单独使用永久性碘125(I-125)种子植入(PI)和随后进行束外放射治疗之间的剂量学优势的差异(EBRT)用于前列腺癌。我们回顾了62例局限性前列腺癌患者的病历,他们使用游离种子或IBCL种子接受了I-125的经会阴间质近距离放射治疗。 24名低危和中危患者单独接受PI的处方剂量为160?Gy,39例高危患者接受PI的剂量为110?Gy,其次为EBRT的45?Gy(PI + EBRT)。收集并分析植入后1个月的术中和植入后剂量参数。 PI组植入游离种子和IBCL种子的患者分别为14(58.3%)和10(41.7%),而PI + EBRT分别为25(65.8%)和13(34.2%)组。在PI组中,尽管术中剂量测定的前列腺V100(p?=?0.003)和D90(p?=?0.009)和直肠V100(p?=?0.026)有显着差异,但术后没有发现这些差异。 -植入物剂量法。在PI + EBRT组中,IBCL种子的剂量学参数,例如前列腺V200(p?=?0.013)和V250(p?=?0.010)和尿道D30(p?=?0.038),比术中用剂量测定游离种子。此外,即使在植入后剂量测定中,前列腺D90(p≤0.004),V150(p≤0.001)和均一性指数(HI,p = 0.001)以及V200(p = 0.001)也是如此。 0.001)和V250(p?=?0.020),尿道D5(p?=?0.008)和D30(p?=?0.003)的剂量质量比IBCL种子好。每个PI和PI + EBRT组的游离种子和IBCL种子之间的手术时间没有显着差异。我们的结果表明,在以较低的规定剂量(例如PI + EBRT)而非单独使用PI进行永久植入的情况下,使用IBCL种子可以获得更大的剂量学益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号